Double-Blind, Randomized, Placebo -Controlled Study to Evaluate the Efficacy of Pre-Operative Administration of Etoricoxib 120 mg, Etoricoxib 120 mg and Paracetamol 1 g Combination or Placebo in the Treatment of Postoperative Pain in Patients Undergoing Gynaecologic Laparoscopic Surgery.

Trial Profile

Double-Blind, Randomized, Placebo -Controlled Study to Evaluate the Efficacy of Pre-Operative Administration of Etoricoxib 120 mg, Etoricoxib 120 mg and Paracetamol 1 g Combination or Placebo in the Treatment of Postoperative Pain in Patients Undergoing Gynaecologic Laparoscopic Surgery.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 25 Apr 2014

At a glance

  • Drugs Etoricoxib (Primary) ; Paracetamol
  • Indications Postoperative pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 30 Jan 2012 Actual patient number added 40 according to ClinicalTrials.gov.
    • 30 Jan 2012 Actual initiation date (Jun 2010) added as reported by ClinicalTrials.gov.
    • 30 Jan 2012 Status changed from not yet recruiting to discontinued as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top